Immersive Physical Therapy in the Neonatal Intensive Care Unit (NICU)
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Apr 11, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how a special physical and occupational therapy program in the Neonatal Intensive Care Unit (NICU) can help parents manage their stress and better care for their premature infants. The researchers want to see if this therapy helps families feel more confident and supported as they navigate the challenges of having a baby born very early.
To participate in this trial, infants must be born before 28 weeks of pregnancy and be admitted to the Newborn Critical Care Center within the first two days of life. Additionally, parents must be the biological mother, at least 18 years old, and able to speak either English or Spanish. If you are selected, you will learn more about the therapy and how it can help you and your baby. It's important to note that the trial is not yet recruiting participants, so this is an early stage in the research process.
Gender
ALL
Eligibility criteria
- Infant Inclusion Criteria:
- • \<28 weeks gestation at birth
- • born or transferred to UNC's Newborn Critical Care Center within the first 48 hours of life
- • If in the SBU or Immersive PT groups: Must be cared for at certain UNC Hospital locations through at least 34 weeks postmenopausal age
- Infant Exclusion Criteria:
- • Has a high likelihood of transferring to an outside hospital
- • Has a genetic abnormality, congenital neurological or musculoskeletal disorder
- Maternal Inclusion Criteria:
- • Is the biological parent
- • Sex is female
- • Understands English or Spanish Language
- • Is at least 18 years of age
- Maternal Exclusion Criteria:
- • Is not the biological parent
- • Sex is male
- • Does not understand English or Spanish language
- • Is under 18 years of age
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Dana McCarty, PT, DPT, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported